AbClon Inc. (KOSDAQ: A174900)
Health Care · Biotechnology · KR
₩25,550.00
-8.42% today · +31.0% 1Y
AbClon Inc. (KOSDAQ: A174900) operates in the Biotechnology industry within the Health Care sector. The company is valued at $379.19M.
Over the last twelve months the share price has gained 31.0%, trading between 16.25K and 95.80K.
Tweenvest scores AbClon Inc. across four factors: quality 48/100, value 62/100. Its strongest factor is value.
A174900 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $379.19M
- Revenue (TTM)
- $3.43M
- P/E
- —
- EPS
- -907.64
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- ₩95,800.00
- 52-week low
- ₩16,250.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.95M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kyverna Therapeutics, Inc.NasdaqGS: KYTX | $384.05M | $6.21 | -2.82% |
| Zura Bio LimitedNasdaqCM: ZURA | $383.32M | $4.00 | 0.00% |
| Heartseed Inc.TSE: 219A | $381.84M | ¥2,641.00 | +2.40% |
| Beijing Luzhu Biotechnology Co., Ltd.SEHK: 2480 | $380.46M | HK$15.01 | +12.01% |
| C4 Therapeutics, Inc.NasdaqGS: CCCC | $376.46M | $3.06 | -3.16% |
| Fennec Pharmaceuticals Inc.NasdaqCM: FENC | $375.57M | $10.72 | +0.09% |
| Hansa Biopharma AB (publ)OM: HNSA | $365.97M | Skr36.12 | +0.44% |
| ProKidney Corp.NasdaqCM: PROK | $363.53M | $1.67 | -4.02% |
Figures last refreshed Oct 11, 2026.